Skip to main content

Frank Pasqualone

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Frank Pasqualone

Frank Pasqualone is recorded as Board Member at Enveric Biosciences, Inc. (ENVB). Enveric Biosciences, Inc. reported in an 8-K filed November 2, 2023 that Frank Pasqualone was appointed director, effective November 2, 2023. Enveric Biosciences, Inc. reported in an 8-K filed July 18, 2022 that Frank Pasqualone was appointed director of the Board, effective July 13, 2022.

“Election of five directors, to serve until the Company’s 2024 annual meeting of stockholders or until their successors are duly elected and qualified.”
Enveric Biosciences, Inc. Form 8-K, filed November 2, 2023 · Read the filing
“On July 13, 2022, Frank Pasqualone was appointed to the board of directors (the "Board") of Enveric Biosciences, Inc. (the "Company"), to serve as a director of the Board, to fill a vacancy as a result of the increase in the size of the Board from eight to nine persons, effective as of the same date, for a term expiring at the 2022 annual meeting of the Company's stockholders, or until Mr. Pasqualone's successor is duly elected and qualified, or his earlier death, resignation or removal.”
Enveric Biosciences, Inc. Form 8-K, filed July 18, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Enveric Biosciences, Inc. (ENVB)

    Board Member

    Proxy statement

    Current

    Start not stated–present

  • Theravance Biopharma, Inc.

    Proxy statement

    Start not stated–2021-03-22

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Theravance Biopharma, Inc.

Leadership on record at Enveric Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.